Atopic dermatitis in Chinese patients shows TH2/TH17 skewing with psoriasiform features
TC Chan, RD Sanyal, AB Pavel, J Glickman… - Journal of Allergy and …, 2018 - jacionline.org
4. Schafer PH, Parton A, Gandhi AK, Capone L, Adams M, Wu L, et al. Apremilast, a cAMP
phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a
model of psoriasis. Br J Pharmacol 2010; 159: 842-55. 5. Schafer P. Apremilast mechanism
of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 2012; 83:
1583-90. 6. Schafer PH, Parton A, Capone L, Cedzik D, Brady H, Evans JF, et al. Apremilast
is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal 2014; 26 …
phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a
model of psoriasis. Br J Pharmacol 2010; 159: 842-55. 5. Schafer P. Apremilast mechanism
of action and application to psoriasis and psoriatic arthritis. Biochem Pharmacol 2012; 83:
1583-90. 6. Schafer PH, Parton A, Capone L, Cedzik D, Brady H, Evans JF, et al. Apremilast
is a selective PDE4 inhibitor with regulatory effects on innate immunity. Cell Signal 2014; 26 …